Sprints and steady cardio send different signals through the blood

Exercise is used as therapy for obesity, type 2 diabetes and hypertension, yet the circulating factors that carry those benefits between organs are still incompletely defined in humans. Most people are offered a choice in practice: a few very hard efforts, or a longer moderate session. Whether those two options produce the same internal signalling has never been well mapped. If intensity changes which molecules tissues release into the bloodstream, then sessions treated as interchangeable may not be biologically equivalent at all. That is the gap this work set out to fill in people rather than animals.

The team ran a multi-cohort human exercise intervention that included sprint-interval exercise and moderate-intensity exercise, in both untrained and trained participants. They profiled the plasma proteome and metabolome to see which circulating proteins and metabolites shifted with intensity. They then integrated multi-organ gene and protein expression datasets, plus tissue sampling in cells and in living tissue, to predict which tissues released each regulated protein and which tissues it was likely acting on. Finally they cross-referenced the intensity-dependent proteins against a large-scale plasma-phenome database linking blood proteins to health traits.

Exercise intensity distinctly influenced both the plasma proteome and the plasma metabolome, and it did so in untrained and trained participants alike. When proteins were mapped back to their likely tissue of origin, muscle fibres and adipocytes stood out as especially sensitive to intensity, undergoing broad secretory and transcriptomic changes. Cross-referencing against the plasma-phenome database picked out intensity-dependent proteins that are associated with cardiometabolic health and disease. What the study did not do is measure anyone's blood pressure, glucose control, body composition or fitness over time, so no clinical benefit of one intensity over the other was demonstrated.

This extends a growing body of work on exercise-released blood factors from single molecules towards a whole-circulation map, and it does so across intensities rather than treating exercise as one thing. It complicates the convenient assumption that matched sessions of different intensity are simply different routes to the same adaptation. The open questions are large: whether these signalling differences accumulate into different long-term outcomes, whether they hold across sex, age and training history, and how many sessions are needed before the pattern matters. Association with health traits in a database is also not the same as showing the proteins cause those traits.

The practical reading is modest. This is a reason to think intensity is a real biological variable rather than just a way to compress a workout into less time, because hard and moderate sessions did not produce the same blood signature. It is not a reason to abandon steady training or to add sprints, since the study measured molecules and not health. If anything, it supports keeping variety in a week and judging your training by outcomes you can actually track. Anyone hoping for a verdict on which intensity is better will have to wait for trials that follow health over time.